News Releases

Date	Title	Additional Formats
May 1, 2026	Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
April 30, 2026	Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
April 20, 2026	Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
April 6, 2026	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
February 26, 2026	Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance (Corrected)
February 23, 2026	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
February 17, 2026	Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
February 5, 2026	Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
January 7, 2026	Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
January 7, 2026	Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants